{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:36:29Z","timestamp":1794015389556,"version":"4.8.0"},"reference-count":21,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2026,2,2]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:p>Mosaicism refers to the presence of multiple cell clones with distinct genotypes arising from a single zygote. The phenotype of mosaic individuals depends on the extent of mosaicism, ranging from localised to almost generalised. We report three diagnostically challenging cases with previously unrecognised mosaicism in the tumour predisposition syndromes (TPS) von Hippel-Lindau syndrome, neurofibromatosis type 1 and neurofibromatosis type 2. In all three patients there was a strong clinical suspicion for a TPS; however, no pathogenic variant (PV) was detected in these patients in DNA extracted from blood. With next generation sequencing (NGS) analysis of multiple affected tissue samples of these patients we were able to detect a recurrent PV at varying variant allele fractions. In all three patients, low-grade mosaicism was in retrospect confirmed in normal tissue and blood (variant allele frequency: 1%\u20137%). Therefore, we conclude that NGS on multiple affected tissues is an effective strategy to detect low-level mosaicism. Identification of previously unrecognised low-grade mosaic cases not only allows for more precise diagnosis and management advice for the index patient, but also accurate genetic counselling for family members.<\/jats:p>","DOI":"10.1136\/jmg-2025-111224","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T18:20:16Z","timestamp":1771352416000},"page":"405-409","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["End of a diagnostic odyssey: the added value of multi-tissue analysis in the identification of mosaicism in tumour predisposition syndromes"],"prefix":"10.1136","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2562-6176","authenticated-orcid":false,"given":"L.","family":"Damen","sequence":"first","affiliation":[{"name":"Department of Human Genetics, Amsterdam UMC Location AMC, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1832-1262","authenticated-orcid":false,"given":"M.F.","family":"Broekema","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Amsterdam UMC Location AMC, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Vogel","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Amsterdam UMC Location AMC, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Korpershoek","sequence":"additional","affiliation":[{"name":"Department of Pathology and Clinical Bioinformatics, Erasmus MC Cancer Center, Rotterdam, ZH, Netherlands"},{"name":"Department of Clinical Genetics, Erasmus MC University Medical Center Rotterdam, Rotterdam, ZH, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Koudijs","sequence":"additional","affiliation":[{"name":"Department of Genetics, University Medical Centre Utrecht, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.R.","family":"Boersma","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Ziekenhuis Amstelland, Amstelveen, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.M.","family":"Dreijerink","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Amsterdam UMC, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.","family":"Zondervan","sequence":"additional","affiliation":[{"name":"Department of Urology, Amsterdam UMC Location AMC, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2160-5207","authenticated-orcid":false,"given":"H.J.","family":"Dubbink","sequence":"additional","affiliation":[{"name":"Department of Pathology and Clinical Bioinformatics, Erasmus MC Cancer Center, Rotterdam, ZH, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.P.","family":"van Hest","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Amsterdam UMC Location AMC, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"2026060310100799000_63.6.405.1","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-020-0877-3"},{"key":"2026060310100799000_63.6.405.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2017.03.019"},{"key":"2026060310100799000_63.6.405.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2015.03.013"},{"key":"2026060310100799000_63.6.405.4","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21387"},{"key":"2026060310100799000_63.6.405.5","doi-asserted-by":"publisher","DOI":"10.1159\/000495956"},{"key":"2026060310100799000_63.6.405.6","doi-asserted-by":"publisher","DOI":"10.1086\/301633"},{"key":"2026060310100799000_63.6.405.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2022.104538"},{"key":"2026060310100799000_63.6.405.8","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1002\/cncr.34265","article-title":"Multidisciplinary integrated care pathway for von Hippel-Lindau disease","volume":"128","author":"Wolters","year":"2022","journal-title":"Cancer"},{"key":"2026060310100799000_63.6.405.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-021-01170-5"},{"key":"2026060310100799000_63.6.405.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2022.05.007"},{"key":"2026060310100799000_63.6.405.11","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/cge.14310","article-title":"Updated protocol for genetic testing, screening and clinical management of individuals at risk of NF2-related schwannomatosis","volume":"103","author":"Halliday","year":"2023","journal-title":"Clin Genet"},{"key":"2026060310100799000_63.6.405.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-019-0598-7"},{"key":"2026060310100799000_63.6.405.13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/pde.12673","article-title":"Mosaic Neurofibromatosis Type 1: A Systematic Review","volume":"33","author":"Garc\u00eda-Romero","year":"2016","journal-title":"Pediatr Dermatol"},{"key":"2026060310100799000_63.6.405.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2009.00977.x"},{"key":"2026060310100799000_63.6.405.15","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jmoldx.2016.06.002","article-title":"Diagnostic Detection of Allelic Losses and Imbalances by Next-Generation Sequencing: 1p\/19q Co-Deletion Analysis of Gliomas","volume":"18","author":"Dubbink","year":"2016","journal-title":"J Mol Diagn"},{"key":"2026060310100799000_63.6.405.16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev-genom-120121-105450","article-title":"Mosaicism in Tumor Suppressor Gene Syndromes: Prevalence, Diagnostic Strategies, and Transmission Risk","volume":"23","author":"Chen","year":"2022","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"2026060310100799000_63.6.405.17","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.699","article-title":"Somatic mosaicism by a de novo MLH1 mutation as a cause of Lynch syndrome","volume":"7","author":"Geurts-Giele","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"2026060310100799000_63.6.405.18","doi-asserted-by":"crossref","first-page":"104360","DOI":"10.1016\/j.ejmg.2021.104360","article-title":"Somatic mosaics in hereditary tumor predisposition syndromes","volume":"64","author":"Steinke-Lange","year":"2021","journal-title":"Eur J Med Genet"},{"key":"2026060310100799000_63.6.405.19","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s00381-023-05859-7","article-title":"Hemangioblastoma and mosaic von Hippel Lindau disease: rare presentation and review of the literature","volume":"39","author":"Whitman","year":"2023","journal-title":"Childs Nerv Syst"},{"key":"2026060310100799000_63.6.405.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2007.00122.x"},{"key":"2026060310100799000_63.6.405.21","doi-asserted-by":"crossref","DOI":"10.1038\/s41525-022-00291-3","article-title":"VHL mosaicism: the added value of multi-tissue analysis","volume":"7","author":"Oldfield","year":"2022","journal-title":"NPJ Genom Med"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg-2025-111224","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:58:57Z","timestamp":1780581537000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg-2025-111224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":21,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,5,25]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/jmg-2025-111224"],"URL":"https:\/\/doi.org\/10.1136\/jmg-2025-111224","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]}}}